Browsing Tag
neuropsychiatric disorders
1 post
Entropy Neurodynamics (ASX: ENP) hits TRP-8803 trial milestone as IV psilocin approach draws patient momentum
Entropy Neurodynamics (ASX: ENP) completes Cohort 1 recruitment for its TRP-8803 IV psilocin BED trial. Here's what the milestone means for investors. Read more.